Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status updated to closed for the study. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading was standardized, and the site revision note updated to v3.6.0.SummaryDifference0.5%

- Check21 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page or its template. This update appears to be a metadata/versioning change rather than a modification to the study content or data presented.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's revision label has been updated from v3.5.3 to v3.5.4, indicating a small maintenance update to the page metadata rather than a change to the study details.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a new build of the page in the revision history. This change is a metadata update with no impact on user-facing information.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 as part of the site version update.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page. This is a metadata update that does not modify study details.SummaryDifference0.1%

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.